Current Value
$2.921 Year Return
Current Value
$2.921 Year Return
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| GDX | 0.03% | $15.35B | 0.51% |
| GOAU | 0.05% | $124.23M | 0.6% |
| SHYM | 0.05% | $355.87M | 0.35% |
| CTA | 0.07% | $1.07B | 0.76% |
| SPSK | 0.15% | $326.14M | 0.5% |
| BNO | 0.17% | $108.34M | 1% |
| USO | 0.22% | $1.03B | 0.6% |
| KCCA | 0.30% | $109.01M | 0.87% |
| TFLO | -0.42% | $6.73B | 0.15% |
| OUNZ | -0.46% | $1.74B | 0.25% |
| IEI | 0.50% | $15.68B | 0.15% |
| CMBS | -0.53% | $456.43M | 0.25% |
| SHY | 0.55% | $23.69B | 0.15% |
| SOYB | 0.58% | $26.41M | 0.22% |
| JMST | -0.60% | $4.09B | 0.18% |
| AAAU | -0.62% | $1.56B | 0.18% |
| GLD | -0.70% | $100.91B | 0.4% |
| IBD | -0.74% | $391.63M | 0.43% |
| SGOL | -0.76% | $5.21B | 0.17% |
| USDU | 0.80% | $129.88M | 0.5% |
Double maintains 2 strategies that include IBRX - ImmunityBio, Inc.
SeekingAlpha
ImmunityBioâs ANKTIVA shows promise, but modest growth, high cash burn, and rising competition raise red flags. Read why IBRX stock is a sell.
Yahoo
The U.S. market is currently experiencing a mix of volatility and optimism, with investor sentiment being influenced by renewed tariff threats and record highs in major indices like the S&P 500 and Nasdaq Composite. In this environment, identifying high growth tech stocks requires careful consideration of their potential to thrive amidst economic uncertainties, driven by innovation and strong market positioning.
Yahoo
Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease worldwide, a toll that is projected to rise in the coming decades (https://ibn.fm/dyQrw). By 2050, the American Cancer Society estimates that annual cancer diagnoses will reach 35 million. While advances in treatment have improved outcomes for some patients, the demand for more effective therapies remains urgent — and the opportunity for innovation and market impact is signif
Yahoo
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.1% and the actively trad
Finnhub
CULVER CITY - ImmunityBio, Inc. announced that the UK Medicines and Healthcare products Regulatory Agency has granted marketing authorization for ANKTIVA in combination with Bacillus...
Yahoo
CULVER CITY, Calif., July 08, 2025--ImmunityBio, Inc. (NASDAQ: IBRX) today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for ANKTIVA® (nogapendekin alfa inbakicept-pmln) in combination with Bacillus Calmette-Guérin (BCG) for the treatment of certain bladder cancer patients. This is the first marketing approval outside the U.S. for this novel lymphocyte-stimulating agent.
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CBOE | -12.48% | $24.71B | +36.77% | 1.07% |
| SAND | -9.96% | $2.88B | +71.80% | 0.59% |
| HCA | -8.79% | $91.53B | +20.02% | 0.72% |
| GFI | -8.60% | $21.69B | +51.82% | 2.28% |
| AU | -6.69% | $24.15B | +65.64% | 2.14% |
| DRD | -5.63% | $1.18B | +42.77% | 2.05% |
| EGO | -5.28% | $4.21B | +23.18% | 0.00% |
| VIV | -5.04% | $18.00B | +28.81% | 0.69% |
| EQX | -4.92% | $4.77B | +5.89% | 0.00% |
| KGC | -4.86% | $19.13B | +70.94% | 0.77% |
| AGI | -4.76% | $11.16B | +51.14% | 0.38% |
| HMY | -4.71% | $8.96B | +52.38% | 1.21% |
| HUSA | -4.48% | $20.46M | -9.15% | 0.00% |
| T | -4.33% | $195.43B | +46.18% | 4.11% |
| BTCT | -3.73% | $29.39M | +101.55% | 0.00% |
| IMMP | -3.32% | $246.81M | -17.16% | 0.00% |
| CME | -3.30% | $99.84B | +44.13% | 1.75% |
| TK | -3.26% | $643.42M | +22.54% | 0.00% |
| UHS | -3.25% | $11.82B | +2.67% | 0.43% |
| K | -2.91% | $27.64B | +41.46% | 2.87% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -28.46% | $310.24M | 1.43% |
| VIXY | -28.11% | $200.94M | 0.85% |
| VIXM | -23.87% | $22.99M | 0.85% |
| TAIL | -23.31% | $94.90M | 0.59% |
| IVOL | -15.50% | $341.06M | 1.02% |
| TPMN | -9.75% | $30.86M | 0.65% |
| ULST | -8.42% | $592.71M | 0.2% |
| FXY | -7.77% | $798.58M | 0.4% |
| UNG | -7.05% | $416.42M | 1.06% |
| IBTG | -6.87% | $1.93B | 0.07% |
| FTSD | -6.87% | $233.24M | 0.25% |
| SPTS | -5.99% | $5.78B | 0.03% |
| XONE | -5.93% | $629.16M | 0.03% |
| STPZ | -5.04% | $443.85M | 0.2% |
| STOT | -4.74% | $254.22M | 0.45% |
| UTWO | -4.64% | $376.64M | 0.15% |
| CORN | -4.31% | $43.88M | 0.2% |
| VGSH | -4.05% | $22.70B | 0.03% |
| IBTH | -3.80% | $1.62B | 0.07% |
| WEAT | -3.49% | $124.92M | 0.28% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| RXRX | 41.23% | $2.28B | -35.61% | 0.00% |
| NRIX | 37.60% | $970.14M | -44.05% | 0.00% |
| TWST | 37.21% | $2.26B | -32.68% | 0.00% |
| ARCT | 36.56% | $360.98M | -43.07% | 0.00% |
| OCUL | 36.48% | $1.80B | +33.69% | 0.00% |
| BEAM | 35.99% | $2.13B | -17.37% | 0.00% |
| CRSP | 35.98% | $4.87B | -1.81% | 0.00% |
| KRYS | 35.97% | $4.35B | -27.65% | 0.00% |
| PDSB | 35.92% | $56.22M | -70.89% | 0.00% |
| EDIT | 35.64% | $238.58M | -49.20% | 0.00% |
| ARWR | 35.53% | $2.57B | -35.52% | 0.00% |
| AI | 35.53% | $3.60B | -12.36% | 0.00% |
| VRDN | 35.49% | $1.40B | +16.68% | 0.00% |
| DCI | 35.30% | $8.19B | -3.29% | 1.57% |
| SYRE | 35.02% | $990.40M | -43.02% | 0.00% |
| IMNM | 34.91% | $740.47M | -39.90% | 0.00% |
| COHU | 34.85% | $913.31M | -43.51% | 0.00% |
| VKTX | 34.63% | $3.55B | -46.73% | 0.00% |
| BC | 34.56% | $3.91B | -24.20% | 2.85% |
| XNCR | 34.51% | $629.86M | -55.03% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 44.60% | $5.19B | 0.35% |
| ARKG | 43.93% | $1.10B | 0.75% |
| GNOM | 41.09% | $45.27M | 0.5% |
| IBB | 40.06% | $5.59B | 0.45% |
| QCLN | 39.57% | $429.77M | 0.56% |
| IWC | 39.17% | $846.53M | 0.6% |
| PTH | 39.04% | $97.64M | 0.6% |
| PBE | 38.56% | $233.59M | 0.58% |
| ARKK | 38.38% | $7.18B | 0.75% |
| ERTH | 38.06% | $139.12M | 0.67% |
| PBW | 37.97% | $309.26M | 0.65% |
| IWO | 37.86% | $11.96B | 0.24% |
| KOMP | 37.08% | $2.35B | 0.2% |
| PINK | 36.41% | $132.39M | 0.5% |
| FBT | 36.34% | $1.05B | 0.54% |
| ICVT | 36.33% | $2.71B | 0.2% |
| ULTY | 36.25% | $1.22B | 1.3% |
| VTWO | 35.91% | $12.69B | 0.07% |
| IDRV | 35.90% | $149.57M | 0.47% |
| KJUL | 35.82% | $160.44M | 0.79% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MKTX | 0.01% | $8.15B | -1.09% | 1.39% |
| MUX | 0.02% | $587.93M | +7.40% | 0.00% |
| TRMD | 0.02% | $1.73B | -53.05% | 22.61% |
| ASC | -0.07% | $415.58M | -49.00% | 6.77% |
| IMNN | 0.15% | $10.57M | -63.89% | 0.00% |
| XGN | -0.15% | $154.55M | +257.07% | 0.00% |
| CPSH | -0.19% | $36.61M | +48.24% | 0.00% |
| SKWD | 0.22% | $2.18B | +42.86% | 0.00% |
| PCRX | -0.23% | $1.08B | +9.44% | 0.00% |
| ZCMD | 0.30% | $28.79M | -11.91% | 0.00% |
| SBS | -0.30% | $13.60B | +32.51% | 3.30% |
| KR | -0.30% | $47.78B | +38.66% | 1.78% |
| LUMN | 0.31% | $4.72B | +280.17% | 0.00% |
| FDP | 0.32% | $1.62B | +52.79% | 3.28% |
| BVN | 0.37% | $4.24B | -3.52% | 0.00% |
| FATBB | -0.39% | $47.67M | -15.39% | 10.47% |
| FRO | -0.44% | $4.14B | -21.16% | 7.26% |
| CCEC | 0.45% | $1.02B | +3.91% | 2.42% |
| IRWD | 0.51% | $119.44M | -88.61% | 0.00% |
| MSEX | 0.52% | $998.16M | -4.33% | 2.43% |
